Marketing Ethics in Pharmaceuticals: An Indian Case Study of Selected Companies

This study investigates the ethical dimensions of pharmaceutical marketing practices in India through a case study of six selected companies (three domestic and three multinational). Using a mixed-methods approach, the research collected data from 120 marketing executives, 80 physicians, and 30 pharmacists. Quantitative analysis reveals that while 85% of marketing executives are aware of ethical codes, only 60% have received formal ethics training in the past year. Incentive-driven sales targets strongly correlate with higher frequencies of ethically questionable practices (r = 0.64, p < 0.01). Physicians report that 72% of promotional claims are sometimes exaggerated, and 48% have experienced direct prescription pressure. The study highlights the gap between corporate policy and field practice, and proposes regulatory, training, and incentive-structure reforms.

Authors

Publication Details

Journal
European Economic Letters (EEL)
Published
2025-08-18
DOI
https://doi.org/10.52783/eel.v15i4.3583
Primary Topic
Ethics in Business and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Marketing Ethics in Pharmaceuticals: An Indian Case Study of Selected Companies

Prahallad Pujari
European Economic Letters (EEL)
Ethics in Business and Education
article

Marketing Ethics in Pharmaceuticals: An Indian Case Study of Selected Companies

Prahallad Pujari
article en

Abstract

This study investigates the ethical dimensions of pharmaceutical marketing practices in India through a case study of six selected companies (three domestic and three multinational). Using a mixed-methods approach, the research collected data from 120 marketing executives, 80 physicians, and 30 pharmacists. Quantitative analysis reveals that while 85% of marketing executives are aware of ethical codes, only 60% have received formal ethics training in the past year. Incentive-driven sales targets strongly correlate with higher frequencies of ethically questionable practices (r = 0.64, p < 0.01). Physicians report that 72% of promotional claims are sometimes exaggerated, and 48% have experienced direct prescription pressure. The study highlights the gap between corporate policy and field practice, and proposes regulatory, training, and incentive-structure reforms.

European Economic Letters (EEL)Vol. 15(4)
Openalex Percentile: Top 79%
Ethics in Business and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.